Fluorouracil Supplemented With Oxaliplatin or Irinotecan for Solid Tumors: Indications From Clinical Characteristics and Health Outcomes of Patients

Fluorouracil combined with oxaliplatin (FOLFOX) and fluorouracil combined with irinotecan (FOLFIRI) are both first-line clinical chemotherapy regimens. However, clinicians' selection of FOLFIRI or FOLFOX medication regimens and their effects on patients' health outcomes are not clear. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Qingwei, Zhao, Dongsheng, Hong, Duo, Lv, Youlei, Wang, Songxia, Yu, Ziqi, Ye, Lanjuan, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7492525/
https://www.ncbi.nlm.nih.gov/pubmed/32984012
http://dx.doi.org/10.3389/fonc.2020.01542

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7492525/
https://www.ncbi.nlm.nih.gov/pubmed/32984012
http://dx.doi.org/10.3389/fonc.2020.01542

Ejemplares similares